Dear followers, we are transitioning from X and will be closing this account shortly. Don't miss out on our updates! Follow us on LinkedIn and BlueSky.
🔗LinkedIn:https://t.co/lLpHUvBzSh
🔗BlueSky:https://t.co/dkl85bqUM3
Explore the latest in intensive care medicine! New research on AKI drugs, ECMO transport safety, & ARDS screening is now in the Journal of Intensive Medicine. APC waived until June 2025 and first Impact Factor coming June 2025! Submit your work today! https://t.co/fXXihnfPi0
Explore the latest in intensive care medicine! New research on AKI drugs, ECMO transport safety, & ARDS screening is now in the Journal of Intensive Medicine. APC waived until June 2025 and first Impact Factor coming June 2025! Submit your work today! https://t.co/2cFF2BiKhc
Explore the latest in intensive care medicine! New research on AKI drugs, ECMO transport safety, & ARDS screening is now in the Journal of Intensive Medicine. APC waived until June 2025 and first Impact Factor coming June 2025! Submit your work today! https://t.co/5AOWWCItou
Explore the latest in intensive care medicine! New research on AKI drugs, ECMO transport safety, & ARDS screening is now in the Journal of Intensive Medicine. APC waived until June 2025 and first Impact Factor coming June 2025! Submit your work today! https://t.co/HFeE34B5NS
On Apr 29, Rare celebrates Global Undiagnosed Day! Seeing a child/adult w/ undiagnosed diseases on Apr 29? Share your story! Join virtual roundtable (Apr 30) to present a case (w/ family consent). Register: https://t.co/sWcEPLvRYh. Wilhelm Foundation (UDNI member) supports!